Autoimmunity: me against myself…
A Café Scientifique organised by the Research Institute of the MUHC and the Montreal Neurological Institute, supported by the Canadian Institutes of Health research
What happens when our immune systems attack our own bodies? The
answer is complex and could be called: type 1 diabetes, multiple
sclerosis, psoriasis, or lupus… And these are only a few of the
so-called autoimmune diseases. Are they triggered by independent
factors, or are they different aspects of the same underlying
condition?
Many of the best research teams are now trying to answer these
questions. What they learn may profoundly change how we view and
treat these pathologies.
Join our panel of top scientists from the Research Institute of the
MUHC and the Montreal Neurological Institute to learn about and
discuss the latest research findings on autoimmunity.
Dr Constantin Polychronakos - Director of
Pediatric Endocrinology at the MUHC
Dr Ciriaco Piccirillo - Director of the laboratory of immuno-regulation in the department of microbiology at the Research Institute of the MUHC
Dr Amit Bar-Or - Director of the Experimental Therapeutics Program, and Scientific Director of the Clinical Research Unit at the Montreal Neurological Institute
Ìý
When? Tuesday April 21st, 2009 at 7:00pm
Where? O Patro Vys - 356, Mont Royal Est
The evening will be hosted by Gerri Barrer, the CBC News health
specialist reporter, based in Montreal
Admission is free
Refreshments will be served.
The Research Institute of the Ã山ǿ¼é Health
Centre (RI MUHC) is a world-renowned biomedical and
health-care hospital research centre. Located in Montreal, Quebec,
the institute is the research arm of the MUHC, the university
health center affiliated with the Faculty of Medicine at Ã山ǿ¼é
University. The institute supports over 600 researchers, nearly
1200 graduate and post-doctoral students and operates more than 300
laboratories devoted to a broad spectrum of fundamental and
clinical research. The Research Institute operates at the forefront
of knowledge, innovation and technology and is inextricably linked
to the clinical programs of the MUHC, ensuring that patients
benefit directly from the latest research-based knowledge.
The Research Institute of the MUHC is supported in part by the
Fonds de la recherche en santé du Québec.
For further details visit: .
-30-